CD1d levels in peripheral blood of patients with acute myeloid leukemia and acute lymphoblastic leukemia

By                  

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 825-830

Spandidos Publications

Access to resources Recommend Favorite

PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes

By Qin Ya-Zhen   Zhu Hong-Hu   Liu Yan-Rong   Wang Ya-Zhe   Shi Hong-Xia   Lai Yue-Yun   Xu Lan-Ping   Liu Dai-Hong   Jiang Qian   Li Ling-Di   Jiang Bin   Liu Kai-Yan   Huang Xiao-Jun  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1442-1449

Informa Healthcare

Access to resources Recommend Favorite

Differential expression of minimal residual disease markers in peripheral blood and bone marrow samples from high-risk neuroblastoma patients

By                            

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 3228-3232

Spandidos Publications

Access to resources Recommend Favorite

Mutated NPM1 in patients with acute myeloid leukemia in remission and relapse

By Jain Preetesh   Kantarjian Hagop   Patel Keyur   Faderl Stefan   Garcia-Manero Guillermo   Benjamini Ohad   Borthakur Gautam   Pemmaraju Naveen   Kadia Tapan   Daver Naval   Nazha Aziz   Luthra Raja   Pierce Sherry   Cortes Jorge   Ravandi Farhad  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1337-1344

Informa Healthcare

Access to resources Recommend Favorite

Serum peptidomic profiling identifies a minimal residual disease detection and prognostic biomarker for patients with acute leukemia

By                              

Oncology Letters, Vol. 6, Iss. 5, 2013-01 ,pp. : 1453-1460

Spandidos Publications

Access to resources Recommend Favorite